ZCCHC4 and neoplasm: IHC results showed a decrease in the molecular marker Ki-67 for cell proliferation in ZCCHC4 deficient tumors compared to overexpression group, suggesting that ZCCHC4 may be a driving factor for CRC tumor development (Fig. 3G).